Sun Pharma says it sought re-inspection of its Halol facility, awaiting US FDA response

Published: 12/08/2017
Sun Pharma says it sought re-inspection of its Halol facility, awaiting US FDA response
Source: WWW.MONEYCONTROL.COM

“The remedial steps to address these observations are now complete and we are now awaiting a re-inspection by the US FDA,” said Dilip Shanghvi, Managing Director of Sun Pharma

Read more
Related news
Comment
Latest in blog
FACEBOOK